Subtotal $0.00
Information only, not available for purchase.
Retatrutide. Regulatory status: Investigational – not FDA-approved.
Availability: Out Of Stock
Triple GIP, GLP-1 and glucagon receptor agonist in late-stage clinical trials.
US regulatory status: Investigational – not FDA-approved.
| Regulatory status | Investigational – not FDA-approved |
|---|
Only logged in customers who have purchased this product may leave a review.
Shop Now
Reviews
There are no reviews yet.